Test Bank For Understanding Pharmacology Essentials for Medication Safety, 2nd Edition by M. Linda Workman & LaCharity ISBN;9781455739769 All Chapters 1-32 Fully Covered |COMPLETE GUIDE A+|.

TEST BANK
$o




Understanding Pharmacology
$o




by M. Linda Workman, Linda A. LaCharity
$o $o $o $o $o $o




2nd Edition
$o




ALL $oCHAPTERS $oINCLUDED $o⬛
$ o $ o ⬛
$ o $ o ⬛




ALL $oANSWERS $oINCLUDED $o⬛$o⬛$o⬛$o

, Test Bank For Understanding Pharmacology, Essentials for Medication Safety,
2nd Edition,Workman & LaCharity

Chapter 01: Drug Regulation, Actions, and Responses

MULTIPLE CHOICE

BASIC CONCEPTS

1. Which health care professional has the major responsibility for dispensing prescribed
drugs under the direction of a pharmacist?
a. Physician
b Nurse practitioner
.
c. Licensed nurse
d Pharmacy technician
.


ANS: D
The physician and nurse practitioner have the major responsibility for prescribing drugs, not
dispensing them. The licensed nurse has the primary responsibility for administering drugs,
although under some circumstances a licensed nurse may dispense prescribed drugs but this is
not his or her major responsibility in drug therapy. The pharmacy technician has the major
responsibility of dispensing prescribed drugs under the direction of a licensed pharmacist.

DIF: Cognitive Level: Remembering REF: p. 3

2. Which term describes the effect of a drug that improves body function?
a. Side effect
b Intended action
.
c. Adverse reaction
d Idiosyncratic response
.


ANS: B
The purpose of drug therapy is to take a drug to prevent, reduce, or correct a health problem.
This response is any drug’s intended action also known as a therapeutic response.

DIF: Cognitive Level: Remembering REF: p. 3

3. Which type of drug name is “owned” by the company that manufactures it?
a. Generic name
b Chemical name

, .
c. Category $oname
d Trade $oname
.


ANS: $ o D
The $ochemical $oname $ois $oa $odrug’s $oexact $ochemical $ocomposition. $oThe $ogeneric $oname $ois $othe
$oname $oassigned $oto $othe $odrug $oby $othe $oU.S. $oAdopted $oNames $oCouncil $oand $ois $onot $oowned $oby

$oanyone. $oThe $ocategory $oname $orefers $oto $othe $otype $oof $odrug $o(what $oit $odoes $oor $owhat $oit $ois $oused

$ofor) $oand $ois $onot $oan $oactual $odrug $oname. $oThe $otrade $oname $o(brand $oname) $ois $othe $oname

$oprovided $oand $oowned $oby $oa $ospecific $odrug’s $omanufacturer.




DIF: Cognitive $oLevel: $oRemembering REF: p. $o4

4. Which $odrug $oor $odrug $oclass $ois $oa $o“high $oalert” $odrug?
a. Penicillin
b Insulin
.
c. NSAIDs
d Calcium
.


ANS: $ o B
A $ohigh $oalert $odrug $ois $oone $oin $owhich $oharm $ois $olikely $oto $oresult $oif $ogiven $oat $othe $owrong $odose,
$oto $othe $owrong $opatient, $oor $onot $ogiven $oto $othe $ocorrect $opatient. $oDrugs $oclassified $oas $ohigh $oalert

$odrugs $oinclude $opotassium, $onarcotics $o(opioids), $oinsulin, $ocancer $ochemotherapy $odrugs, $oand

$oheparin $o(or $oany $odrug $othat $ostrongly $oaffects $oblood $oclotting). $oPenicillin, $oNSAIDs, $oand

$ocalcium $oare $onot $oconsidered $ohigh $oalert $odrugs.




DIF: Cognitive $oLevel: $oRemembering REF: p. $o4

5. What $ois $othe $oterm $ofor $oa $odrug $othat $ohas $othe $osame $oaction $oas $oa $onaturally
$ooccurring $obody $ohormone $oor $oenzyme?

a. Agonist
b Blocking
. $oagent
c. Chemical
d Duplicator
.


ANS: $ o A
A $odrug $oagonist $ois $oan $oextrinsic $odrug $othat $oactivates $othe $oreceptor $osites $oof $oa $ocell $oand
$omimics $othe $oactions $oof $onaturally $ooccurring $obody $osubstances $o(intrinsic $odrugs). $oA

$oblocking $oagent $ois $oa $odrug

, antagonist. $oA $ochemical $owould $onot $onecessarily $obe $oa $odrug $oat $oall. $oA $oduplicator $ois $onot $oa
$opharmacologic $oterm.




DIF: Cognitive $oLevel: $oRemembering REF: pp. $o6-7

6. Which $oterm $odescribes $ohow $othe $obody $oaffects $odrug $oactivity?
a. Drug $opotency
b Pharmacodynamics
.
c. Therapeutic $oeffect
d Pharmacokinetics
.


ANS: $ o D
The $oterm $opharmacokinetics $orefers $oto $odrug $ometabolism $oand $ohow $othe $obody $ochanges $oa
$odrug. $oPharmacodynamics $orefers $oto $ohow $oa $odrug $oworks $oto $ochange $obody $ofunction. $oDrug

$opotency $orefers $oto $ohow $ostrongly $oor $oto $owhat $odegree $oa $odrug $oexerts $oits $oeffects. $oThe

$otherapeutic $oeffect $ois $ocloser $oto $opharmacodynamics, $omeaning $ohow $oa $odrug $oworks $oto

$ochange $obody $ofunction.




DIF: Cognitive $oLevel: $oRemembering REF: p. $o10

7. In $othe $oUnited $oStates, $owhich $ogroup $ois $oresponsible $ofor $oenforcing $oestablished
$ostandards $ofor $odrug $omanufacturing?

a. U.S. $oPharmacopeia
b National $oInstitutes $oof $oHealth
.
c. Food $oand $oDrug $oAdministration
d Association $oof $oPharmaceutical
. $oManufacturers


ANS: $ o C
The $ostandards $ofor $odrug $omanufacture $oare $oestablished $oby $othe $oU.S. $oPharmacopeia. $oThese
$ostandards $oare $oenforced $oby $othe $oFood $oand $oDrug $oAdministration. $oNeither $othe $oNational

$oInstitutes $oof $oHealth $onor $othe $oAssociation $oof $oPharmaceutical $oManufacturers $ohas $oany

$oauthority $oto $oenforce $odrug $ostandards.




DIF: $ o $ o Cognitive $oLevel: $oRemembering $ o $ o $ o $ o REF: $ o $ o p. $o5

8. Which $ofactor $ois $oa $omajor $odisadvantage $oof $othe $otransdermal $odrug $odelivery $oroute?
a. Only $oa $oprescriber $ocan $oadminister $odrugs $oby $othe $otransdermal
$oroute.